2.50
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMRA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$2.54
Offen:
$2.44
24-Stunden-Volumen:
7,900
Relative Volume:
0.08
Marktkapitalisierung:
$7.37M
Einnahmen:
$4.88M
Nettoeinkommen (Verlust:
$-3.66M
KGV:
-1.6292
EPS:
-1.5345
Netto-Cashflow:
$-2.80M
1W Leistung:
+8.23%
1M Leistung:
+1.21%
6M Leistung:
-27.11%
1J Leistung:
+4.10%
Biomerica Inc Stock (BMRA) Company Profile
Firmenname
Biomerica Inc
Sektor
Branche
Telefon
(949) 379-2875
Adresse
17571 VON KARMAN AVENUE, IRVINE, CA
Vergleichen Sie BMRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BMRA
Biomerica Inc
|
2.50 | 7.49M | 4.88M | -3.66M | -2.80M | -1.5345 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-10 | Eingeleitet | Colliers Securities | Buy |
| 2018-01-04 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Biomerica Inc Aktie (BMRA) Neueste Nachrichten
Biomerica (NASDAQ:BMRA) versus ProKidney (NASDAQ:PROK) Critical Review - Defense World
Retail Trends: Why Biomerica Inc stock is recommended by analystsRisk Management & Target Return Focused Stock Picks - BỘ NỘI VỤ
Why Biomerica Inc. stock is recommended by analystsJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser
Is Biomerica Inc. stock a good choice for value investorsJuly 2025 Big Picture & AI Enhanced Trading Alerts - Newser
Biomerica (BMRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Biomerica Expands Contract Manufacturing Services - Orange County Business Journal
Is Biomerica Inc. stock a safe haven asset2025 Trading Volume Trends & Safe Capital Investment Plans - BỘ NỘI VỤ
Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly - MarketScreener
Biomerica (BMRA) Showcases Innovative IBS Therapy in Biotherapeu - GuruFocus
Biomerica, Inc. Announces Positive Results from Multicenter Clinical Trial on inFoods® IBS Dietary Therapy - Quiver Quantitative
Biomerica Inc. (BMRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Biomerica Inc. stock appeals to analystsMarket Performance Recap & Breakout Confirmation Alerts - newser.com
Is Biomerica Inc. stock vulnerable to regulatory risksAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
What momentum shifts mean for Biomerica Inc.Portfolio Value Report & Safe Entry Momentum Tips - newser.com
Is Biomerica Inc. stock ready for a breakoutQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Biomerica Inc. stock trendline breakdown2025 Stock Rankings & Weekly High Return Stock Opportunities - newser.com
Can machine learning forecast Biomerica Inc. recovery2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Is it too late to sell Biomerica Inc.Earnings Miss & Technical Entry and Exit Alerts - newser.com
Will Biomerica Inc. stock remain a Wall Street favoriteIndex Update & Fast Momentum Entry Tips - newser.com
What analysts say about Biomerica Inc stockDividend Stock Watch & Small Investment Big Gains - earlytimes.in
How Biomerica Inc. stock compares to market leaders2025 Market Outlook & Low Risk High Win Rate Picks - Fundação Cultural do Pará
How Biomerica Inc. stock reacts to Fed rate cutsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
Will Biomerica Inc. stock maintain growth story2025 Pullback Review & Advanced Technical Analysis Signals - newser.com
Finanzdaten der Biomerica Inc-Aktie (BMRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):